Literature DB >> 15852008

Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.

Yasmina Laouar1, Fayyaz S Sutterwala, Leonid Gorelik, Richard A Flavell.   

Abstract

Interferon-gamma and interleukin 12 produced by the innate arm of the immune system are important regulators of T helper type 1 (T(H)1) cell development, but signals that negatively regulate their expression remain controversial. Here we show that transforming growth factor-beta (TGF-beta) controlled T(H)1 differentiation through the regulation of interferon-gamma produced by natural killer (NK) cells. Blockade of TGF-beta signaling in NK cells caused the accumulation of a large pool of NK cells secreting copious interferon-gamma, responsible for T(H)1 differentiation and protection from leishmania infection. In contrast, blockade of TGF-beta signaling in dendritic cells did not affect dendritic cell homeostasis or interleukin 12 production, thus indicating a previously undescribed demarcation of the function of TGF-beta in NK cells versus dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852008     DOI: 10.1038/ni1197

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  179 in total

1.  Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Authors:  Racquel Domingo-Gonzalez; Carol A Wilke; Steven K Huang; Yasmina Laouar; Jeanette P Brown; Christine M Freeman; Jeffrey L Curtis; Gregory A Yanik; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

Review 2.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.

Authors:  Li Yang; Yanli Pang; Harold L Moses
Journal:  Trends Immunol       Date:  2010-06-01       Impact factor: 16.687

3.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 4.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

5.  IL-18 stimulates IL-13-mediated IFN-gamma-sensitive host resistance in vivo.

Authors:  Qian Liu; Zhugong Liu; Jeannette Whitmire; Farhang Alem; Hossein Hamed; John Pesce; Joseph F Urban; William C Gause
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

6.  The interleukin-10 inducing effect of transforming growth factor-beta on human naive CD4+ T cells from cord blood is restricted to the TH1 subset.

Authors:  B Kapitein; M M Tiemessen; W M Liu; A G van Ieperen-van Dijk; M O Hoekstra; E van Hoffen; E F Knol
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 7.  Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.

Authors:  Nahid Maspi; Amir Abdoli; Fathemeh Ghaffarifar
Journal:  Pathog Glob Health       Date:  2016-09-23       Impact factor: 2.894

8.  TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis.

Authors:  Yasmina Laouar; Terrence Town; David Jeng; Elise Tran; Yisong Wan; Vijay K Kuchroo; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-31       Impact factor: 11.205

Review 9.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

10.  Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells.

Authors:  Shomyseh Sanjabi; Munir M Mosaheb; Richard A Flavell
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.